Winston Crasto is Consultant in Diabetes & Endocrinology at George Eliot Hospital NHS Trust
Current and future treatment options for the management of patients with type 2 diabetes.
Identifying patients at risk of diabetesSubscription
With 11.5 million people at risk in the UK, it is essential to recognise the signs and symptoms of type 1 diabetes and type 2 diabetes.
Hyperglycaemia is a key factor in the pathophysiology of diabetic neuropathy, but other changes also contribute. In type 2 diabetes, dyslipidaemia and disturbances in neuronal insulin sensitivity are thought to play a major role. Changes in insulin signalling are important in patients with type 1 diabetes.